Da Zen Theranostics, Inc.
Personalized diagnostic platform using advanced health technology for patient stratification and treatment guidance
- Sector
- Medtech
- Headquarters
- SAN JOSE, CA
- Founded
- 2017
- Latest Form D
- $5.5M, Dec 2020
- Total capital
- $7.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $7.8M
- 3 Form D · last Dec 2020
- 71 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 9 pending · first 2019
- Rank in peer group#17 of 73
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$5.5M
- Private capital raisedForm D · SEC · 2nd filing$700K
- Private capital raisedForm D · SEC · 1st filing$1.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 73 peers
Line = medianMedtech · Platform
- Granted patents#17 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Bo YuDirectorNamed in SEC Form D filings
- Brian LiuDirectorNamed in SEC Form D filings
- Leland ChungDirectorNamed in SEC Form D filings
- Qinqhua ZhouDirectorNamed in SEC Form D filings
- Yu-Ping ChengExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 13- GrantedOrganic Anion Transporting Peptide-Based Cancer Imaging and TherapyUSPTOUS 12,414,996
- GrantedCompounds And Methods To Sensitize Cancer Cells To CisplatinUSPTOUS 12,121,510
- PendingHeptamethine Carbocyanine Dye-dota Conjugates Complexed With LUTETIUM-177, YTTRIUM-90, Or GALLIUM-68, And Their Uses For Image-guided RadiotherapyUSPTOApplication 18270463
Show all 13 patent records
- Organic Anion Transporting Peptide-Based Cancer Imaging and TherapySep 16, 2025 · US 12,414,996Granted
- Compounds And Methods To Sensitize Cancer Cells To CisplatinOct 22, 2024 · US 12,121,510Granted
- Heptamethine Carbocyanine Dye-dota Conjugates Complexed With LUTETIUM-177, YTTRIUM-90, Or GALLIUM-68, And Their Uses For Image-guided RadiotherapySep 19, 2024 · Application 18270463Pending
- Compounds And Methods To Sensitize Cancer Cells To Tyrosine Kinase InhibitorsJan 23, 2024 · US 11,878,000Granted
- Artemisinin DerivativesJul 20, 2023 · Application 18123240Pending
- Tumor Homing Statin DerivativesApr 13, 2023 · Application 18076213Pending
- Artemisinin DerivativesFeb 18, 2021 · Application 16926033Pending
- Tumor Homing Statin DerivativesJan 14, 2021 · Application 16925582Pending
- Organic Anion Transporting Peptide-based Cancer Imaging And TherapyAug 8, 2019 · Application 16390384Pending
- Organic Anion Transporting Peptide-based Cancer Imaging And TherapyJun 4, 2019 · US 10,307,489Granted
- Heptamethine Carbocyanine Dye-dota Conjugates Complexed With LUTETIUM-177, YTTRIUM-90, Or GALLIUM-68, And Their Uses For Image-guided RadiotherapyApplication PCTUS2021065651Pending
- Heptamethine Carbocyanine Dye-cross-bridged Tetraamine Cyclam (ctc) Chelator Conjugates, Their Stable Complexes With COPPER-64, And Uses ThereofApplication PCTUS2022019695Pending
- Compounds And Methods To Sensitize Cancer Cells To Tyrosine Kinase InhibitorsApplication PCTUS2017057761Pending
Related companies, and why
- Noleus Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- Nia Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
- ORTHOBOND CORPORATIONSimilar federal contract value in Medtech · null in contracts
- Amplify Surgical, Inc.Similar federal contract value in Medtech · null in contracts
- Holobeam Technologies Inc.Similar federal contract value in Medtech · null in contracts
- BIODTECH, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .